Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Drug Design Program, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
Cell Biochem Biophys. 2023 Dec;81(4):717-726. doi: 10.1007/s12013-023-01168-7. Epub 2023 Sep 1.
Accumulating data confirms that Methotrexate (MTX), a well-known immunosuppressive and anticancer drug, causes nephrotoxicity. Infliximab (INF), the inhibitor of tumor necrosis factor-alpha (TNF-α), was proven to have anti-inflammatory properties. Thus, it may have potential in preventing MTX-induced nephrotoxicity. Therefore, this study aimed to inspect the prospective nephroprotective effect of INF on MTX-induced rat nephrotoxicity through investigating the possible molecular mechanisms, including its interference with different death routes, oxidative stress as well as mitochondrial biogenesis. Rats received an INF intraperitoneal single dose of 7 mg/kg 72 h prior to a single 20 mg/kg MTX injection. MTX nephrotoxicity was demonstrated by significantly increased serum levels of the renal indicators urea and creatinine as well as renal inflammatory markers TNF-α and Interleukin-6 (IL-6) and the renal oxidative stress marker malondialdehyde (MDA), while renal antioxidant enzyme superoxide dismutase (SOD) was significantly decreased compared to control. INF injection prior to MTX markedly reversed these MTX-induced effects. Besides, MTX impaired mitochondrial biogenesis, while INF attenuated this impairment, as indicated by increased expression of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). Finally, MTX triggered apoptotic and autophagic cascades in renal tissues as evidenced by reduced anti-apoptotic Bcl-2 protein expression as well as elevated expression of the pro-apoptotic protein Bax and both key regulators of autophagy; beclin-1 and LC-3, whereas INF pretreatment counteracted these apoptotic and autophagic effects of MTX. Summarily, these results suggest that INF provides protection against MTX-induced nephrotoxicity which could be elucidated by its antioxidant, anti-inflammatory, anti-apoptotic and anti-autophagic effects as well as upregulating mitochondrial biogenesis.
累积的数据证实,甲氨蝶呤(MTX),一种著名的免疫抑制剂和抗癌药物,可导致肾毒性。英夫利昔单抗(INF),肿瘤坏死因子-α(TNF-α)的抑制剂,已被证明具有抗炎特性。因此,它可能具有预防 MTX 诱导的肾毒性的潜力。因此,本研究旨在通过研究可能的分子机制,包括其对不同死亡途径、氧化应激和线粒体生物发生的干扰,检查 INF 对 MTX 诱导的大鼠肾毒性的潜在肾保护作用。大鼠在单次 20mg/kg MTX 注射前 72 小时接受单次腹腔内 7mg/kg INF 剂量。MTX 肾毒性表现为血清肾指标尿素和肌酐以及肾炎症标志物 TNF-α和白细胞介素-6(IL-6)以及肾氧化应激标志物丙二醛(MDA)水平显著升高,而与对照组相比,肾抗氧化酶超氧化物歧化酶(SOD)显著降低。INF 注射在 MTX 之前显著逆转了这些 MTX 诱导的作用。此外,MTX 损害了线粒体生物发生,而 INF 减轻了这种损害,这表现为过氧化物酶体增殖物激活受体-γ共激活因子-1α(PGC-1α)的表达增加。最后,MTX 在肾组织中触发了凋亡和自噬级联反应,表现为抗凋亡蛋白 Bcl-2 表达减少以及促凋亡蛋白 Bax 和自噬的两个关键调节剂 beclin-1 和 LC-3 的表达增加,而 INF 预处理则对抗了 MTX 的这些凋亡和自噬作用。总之,这些结果表明,INF 提供了对 MTX 诱导的肾毒性的保护作用,其机制可能是通过抗氧化、抗炎、抗凋亡和抗自噬作用以及上调线粒体生物发生来阐明的。